Compare PPCB & LXEH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PPCB | LXEH |
|---|---|---|
| Founded | 2007 | 2001 |
| Country | Australia | China |
| Employees | N/A | N/A |
| Industry | | Other Consumer Services |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6M | 2.9M |
| IPO Year | 2011 | 2020 |
| Metric | PPCB | LXEH |
|---|---|---|
| Price | $1.02 | $1.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 85.3K |
| Earning Date | 05-16-2026 | 05-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.16 |
| 52 Week High | $6.79 | $3.28 |
| Indicator | PPCB | LXEH |
|---|---|---|
| Relative Strength Index (RSI) | 44.71 | 45.03 |
| Support Level | $0.90 | $1.25 |
| Resistance Level | $1.38 | $1.74 |
| Average True Range (ATR) | 0.29 | 0.07 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 1.59 | 14.29 |
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
Lixiang Education Holding Co Ltd is engaged in providing education services, including high school and vocational education services. It offers private basic education at the primary and junior high school levels. The Group has two reportable segments for operations, including high school and vocational education.